SA
APNHY logo
Aspen Pharmacare Holdings Limited(APNHY)
Closing price · checked 10:11 PM ETAbout this dataData status
$10.15▲0.05 (0.50%)
Extended:$10.15+0.00 (+0.00%)· 10:11 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →
APNHY logo

APNHY ROE

Latest reported3.29%
APNHY FY ROE (34.71% → 3.29%)
Powered by
High-resolution chart · PNG

What is roe?

Return on equity.

Compare roe

Values are from the market snapshot of .

APNHY roe history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.

Aspen Pharmacare Holdings Limited ROE — Annual fiscal periods
Period endingROEChange
3.2935%+4.57 pts
-1.2757%−6.47 pts
5.1897%−0.87 pts
6.0624%−3.08 pts
9.1455%+1.82 pts
7.3232%+0.58 pts
6.7384%−5.18 pts
11.9219%−0.08 pts
12.0039%+0.17 pts
11.8329%+1.72 pts
10.1176%−5.12 pts
15.2361%−2.11 pts
17.3428%+1.90 pts
15.4432%−0.76 pts
16.2041%−3.37 pts
19.5733%+1.31 pts
18.267%−14.09 pts
32.3619%+5.32 pts
27.0436%−3.17 pts
30.2109%−7.31 pts
37.5169%−7.12 pts
44.6337%+11.29 pts
33.3414%−1.37 pts
34.7138%—

Frequently asked questions: APNHY roe

What is Aspen Pharmacare Holdings Limited (APNHY)'s current roe?

Aspen Pharmacare Holdings Limited (APNHY)'s latest reported roe (Fiscal year) is 3.29% as of Jun 30, 2026. Return on equity.

How much historical roe data is available for APNHY?

Stock Alarm Pro provides 24 dated annual fiscal periods observations for Aspen Pharmacare Holdings Limited (APNHY)'s roe, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare APNHY's roe to peers or set an alert?

You can compare APNHY's roe directly against sector peers (LLY, JNJ, ABBV, MRK) on Stock Alarm Pro, open the multi-ticker series in Chart Studio, or set real-time price and valuation alerts on APNHY delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.